Physician profile
Joel Dean
NPI 1568534915
$4,405.76
in general payments reported to CMS, 2019-2025
8 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2022: $311 · 2023: $3,438 · 2024: $88.63 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Food and Beverage: $408 · Travel and Lodging: $215 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Food and Beverage | $407.68 |
| Travel and Lodging | $215.18 |
| Education | $105.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,185.33 | 2019-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Merck Sharp & Dohme LLC | $56.34 | 2024-2025 | Keytruda, Welireg |
| Globus Medical, INC. | $52.99 | 2023 | Alif Instruments (Universal) |
| Astrazeneca Pharmaceuticals LP | $43.66 | 2025 | Lynparza, Tagrisso |
| Daiichi Sankyo INC. | $28.93 | 2025 | Enhertu |
| Ethicon US, LLC | $14.67 | 2019 | |
| Aveo Pharmaceuticals, INC. | $13.66 | 2024 | |
| Ambu INC. | $10.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.